Kaye Edward M. MD — SEC Form 4 filings
SEC reporting owner CIK 1522780. 45 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 45 filings on record, filed 2024-03-19 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 20 filings — 330,367 shares, $9,362,756 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 70.
- Largest priced transaction: sale of 28,064 shares @ $66.72 ($1,872,430) in CYTOKINETICS INC, filed 2025-12-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | Director | 23 | — | 27 legs · 270,351 sh · $5,701,668 | 38 |
| CYTOKINETICS INC (CYTK) | Director | 19 | — | 7 legs · 60,016 sh · $3,661,087 | 21 |
| Avidity Biosciences, Inc. (RNAM) | Director | 3 | — | — | 11 |
Form 4 filings — Kaye Edward M. MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 26,250 @ $0 · Sale (S): 11,930 @ $32.01 · Sale (S): 637 @ $32.47 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 151 @ $82.62 | EDGAR |
| 2026-06-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 2,933 @ $76.09 | EDGAR |
| 2026-05-27 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0 | EDGAR |
| 2026-04-15 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 191 @ $65.37 | EDGAR |
| 2026-03-17 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 35,500 @ $0 · Option exercise (M): 26,250 @ $0 · Option exercise (M): 35,500 (derivative) @ $0 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Avidity Biosciences, Inc. (RNAM) | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 13,489 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +2 more | EDGAR |
| 2026-01-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 197 @ $63.44 | EDGAR |
| 2025-12-10 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 3,825 @ $31.44 · Sale (S): 8,274 @ $32.52 · Sale (S): 1,331 @ $33.10 | EDGAR |
| 2025-12-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 26,250 @ $0 · Sale (S): 5,222 @ $30.76 · Sale (S): 1,231 @ $31.32 · Sale (S): 6,367 @ $31.33 · Sale (S): 1,681 @ $31.15 · Sale (S): 500 @ $31.85 · +1 more | EDGAR |
| 2025-12-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 4,317 @ $0 · Sale (S): 661 @ $29.56 · Sale (S): 405 @ $30.14 · Sale (S): 419 @ $30.34 · Sale (S): 651 @ $30.85 · Option exercise (M): 4,317 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 8,064 @ $12.40 · Option exercise (M): 20,000 @ $14.25 · Sale (S): 28,064 @ $66.72 · Option exercise (M): 8,064 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | CYTOKINETICS INC (CYTK) | Option exercise (M): 5,175 @ $9.66 · Sale (S): 5,175 @ $65.08 · Option exercise (M): 5,175 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 199 @ $62.80 | EDGAR |
| 2025-10-10 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 25,000 @ $0.60 · Sale (S): 25,000 @ $30 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 42,461 @ $25.09 | EDGAR |
| 2025-10-06 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 6,757 @ $60 | EDGAR |
| 2025-09-30 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 6,695 @ $55.08 | EDGAR |
| 2025-09-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Disposition to issuer (D): 178,500 (derivative) @ $0 · Disposition to issuer (D): 144,000 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 1,029 @ $20 · Sale (S): 14,860 @ $20.14 · Sale (S): 45,996 @ $20.13 | EDGAR |
| 2025-09-02 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 6,756 @ $50 | EDGAR |
| 2025-08-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 12,126 @ $18.24 | EDGAR |
| 2025-08-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 26,250 @ $0 · Grant/award (A): 52,500 (derivative) @ $0 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2025-07-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 328 @ $38.01 | EDGAR |
| 2025-06-12 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 6,692 @ $0 · Grant/award (A): 10,034 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | CYTOKINETICS INC (CYTK) | Sale (S): 3,636 @ $32.10 | EDGAR |
| 2025-05-14 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 7,333 @ $0 · Grant/award (A): 10,880 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 324 @ $38.56 | EDGAR |
| 2025-03-20 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 10,382 @ $8.67 · Sale (S): 8,907 @ $8.27 · Grant/award (A): 216,000 (derivative) @ $0 · Grant/award (A): 144,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 35,500 @ $0 · Option exercise (M): 26,250 @ $0 · Option exercise (M): 35,500 (derivative) @ $0 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 255 @ $48.93 | EDGAR |
| 2025-01-02 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 35,000 @ $0.60 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 6,786 @ $12.99 | EDGAR |
| 2024-12-10 | 4/A | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 26,250 @ $0 · Grant/award (A): 52,500 (derivative) @ $0 · Option exercise (M): 26,250 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 6,170 @ $12.78 | EDGAR |
| 2024-12-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 26,500 @ $0 · Grant/award (A): 53,000 (derivative) @ $0 · Option exercise (M): 26,500 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 21,591 @ $0 · Option exercise (M): 21,591 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 237 @ $52.60 | EDGAR |
| 2024-07-03 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 228 @ $0 | EDGAR |
| 2024-06-14 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 13,489 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 159,000 (derivative) @ $0 · Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Stoke Therapeutics, Inc. (STOK) | Sale (S): 39,686 @ $15.39 · Sale (S): 2,664 @ $16.05 | EDGAR |
| 2024-05-16 | 4 | CYTOKINETICS INC (CYTK) | Grant/award (A): 5,600 @ $0 · Grant/award (A): 3,636 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Stoke Therapeutics, Inc. (STOK) | Option exercise (M): 35,500 @ $0 · Sale (S): 11,150 @ $6.10 · Option exercise (M): 35,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1522780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →